Cargando…

Teicoplanin pharmacokinetics during albumin dialysis

Detalles Bibliográficos
Autores principales:	Weiler, Stefan, Falkensammer, Gerda, Seger, Christoph, Joannidis, Michael, Bellmann, Romuald
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016547/ http://dx.doi.org/10.1186/1471-2210-10-S1-A36

Ejemplares similares

Voriconazole and target-site penetration into human tissue
por: Weiler, Stefan, et al.
Publicado: (2008)

Amphotericin B lipid formulations and target-site penetration into human body fluids
por: Weiler, Stefan, et al.
Publicado: (2008)

Single-dose pharmacokinetics of the cholesteryl sulfate complex of amphotericin B in critically ill patients with cholestatic liver failure
por: Weiler, S, et al.
Publicado: (2008)

Pharmacokinetics of anidulafungin during albumin dialysis
por: Aguilar, Gerardo, et al.
Publicado: (2014)

Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections
por: Matsumoto, Kazuaki, et al.
Publicado: (2016)

Between benzodiazepine over-sedation and neurological damage
por: Kountchev, Jordan, et al.
Publicado: (2005)

Pseudocholinesterase and albumin in infants with cirrhosis
por: Popoviê, LJ, et al.
Publicado: (2000)

Population Pharmacokinetics and Dosage Optimization of Teicoplanin in Children With Different Renal Functions
por: Gao, Liuliu, et al.
Publicado: (2020)

Population Pharmacokinetics and Model-Based Dosing Optimization of Teicoplanin in Pediatric Patients
por: Zhang, Tao, et al.
Publicado: (2020)

Population pharmacokinetics and dosing optimization of unbound teicoplanin in Chinese adult patients
por: Fu, Wen-Qian, et al.
Publicado: (2022)

Uremic albumin blocks reverse cholesterol transfer: role of lysine modifications
por: Binder, Veronika, et al.
Publicado: (2011)

Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
por: Bellmann, Romuald, et al.
Publicado: (2017)

Serum albumin and mortality risk in critically ill patients
por: Yap, FHY, et al.
Publicado: (2000)

Dialysis with perfusion lumen catheter in intensive care unit
por: Carron, PL, et al.
Publicado: (2002)

Parenteral nutrition (PN) depresses hepatic albumin synthesis in septic rats
por: O'Leary, MJ, et al.
Publicado: (2000)

Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
por: Chen, Chao‐Yang, et al.
Publicado: (2023)

Uremia-induced lysine modifications transform plasma albumin into a high-density lipoprotein receptor inhibitor
por: Binder, Veronika, et al.
Publicado: (2012)

Catecholamine pharmacokinetics and pharmacodynamics in critical illness
por: Johnston, AJ, et al.
Publicado: (2003)

Characterization of colistin tissue pharmacokinetics by microdialysis
por: Matzneller, Peter, et al.
Publicado: (2012)

Hypertensive reaction to a certain batch of albumin 5%: a case report
por: Heringlake, M, et al.
Publicado: (1998)

Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study
por: Hasslacher, Julia, et al.
Publicado: (2011)

Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis
por: Kountchev, Jordan, et al.
Publicado: (2005)

The influence of the use of human albumin on morbidity/mortality and the costs of hospitalization of critically ill patients
por: Azevedo, JR, et al.
Publicado: (2001)

Does biocompatibility of dialysis membranes affect survival in patients with acute renal failure?
por: Venkataraman, R, et al.
Publicado: (2001)

Pharmacokinetics of dexmedetomidine infusions for patients in the intensive care unit
por: Venn, RM, et al.
Publicado: (2001)

Effects of volume replacement on plasma volume and albumin escape rate in a porcine model of fecal peritonitis
por: Marx, G, et al.
Publicado: (2000)

No evidence of excess mortality in patients receiving human albumin: a meta-analysis of randomized controlled trials
por: Wilkes, MM, et al.
Publicado: (2001)

High normal TSH is associated with retinopathy and increased albumin excretion in euthyroid type 1 diabetic patients
por: Margallo, Leticia Maria Alcantara, et al.
Publicado: (2015)

Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
por: Köglberger, Paul, et al.
Publicado: (2021)

Changes to cardiac output and left ventricular work indices following a 200 ml bolus of 20% albumin
por: Margarson , M, et al.
Publicado: (1997)

EHMTI-0022. Pharmacokinetic variability of drugs used for prophylactic treatment in migraine
por: Pavbro, P, et al.
Publicado: (2014)

Is Therapeutic Drug Monitoring of Teicoplanin Useful?
por: Kim, Shin-Woo
Publicado: (2014)

In vivo / in vitro Correlation of Pharmacokinetics of Gentamicin, Vancomycin, Teicoplanin and Doripenem in a Bovine Blood Hemodialysis Model
por: Vossen, M G, et al.
Publicado: (2021)

Pharmacokinetics of Teicoplanin in a Patient with Coronavirus Disease 2019 Receiving Veno-venous Extracorporeal Membrane Oxygenation
por: Hirayu, Nobuhisa, et al.
Publicado: (2022)

Albumin clearance in the endotoxemic rat after administration of N(ω)-nitro-L-arginine methyl ester (L-name)
por: Metcalf, K, et al.
Publicado: (1999)

Clinical outcomes of teicoplanin use in the OPAT setting
por: Dabrowski, Hannah, et al.
Publicado: (2020)

Tissue pharmacokinetics of individual macrolides support observed differences in development of bacterial resistance
por: Krasniqi, Shaip, et al.
Publicado: (2010)

Pharmacokinetics of meropenem in intensive care patients receiving continuous renal replacement therapy
por: Giles, LJ, et al.
Publicado: (1998)

A comparison of performance enhancing synergy among ultrafiltered yeast extracts and recombinant human serum albumin in CHO-K1 cells
por: Babcock, James F, et al.
Publicado: (2011)

Bioavailability, pharmacokinetics and safety of riociguat given as an oral suspension or crushed tablet with and without food
por: Saleh, Soundos, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rmi5pq9rnl9pj90r7em0ei10ot